Edgar Richard Kramer

Dr. Edgar Richard Kramer

University of Plymouth, Plymouth, UK
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SGStephan Geley
Stephan Geley
Edgar Richard KramerEdgar Richard Kramer
Edgar Richard Kramer
CGChristian Gieffers
Christian Gieffers
JGJulian Gannon
Julian Gannon
JPJan-Michael Peters
Jan-Michael Peters
THTim Hunt
Tim Hunt
Cyclin A is a stable protein in S and G2 phases, but is destabilized when cells enter mitosis and is almost completely degraded before the metaphase to anaphase transition. Microinjection of antibodies against subunits of the anaphase-promoting complex/cyclosome (APC/C) or against human Cdc20 (fizzy) arrested cells at metaphase and stabilized both cyclins A and B1. Cyclin A was efficiently polyubiquitylated by Cdc20 or Cdh1-activated APC/C in vitro, but in contrast to cyclin B1, the proteolysis of cyclin A was not delayed by the spindle assembly checkpoint. The degradation of cyclin B1 was accelerated by inhibition of the spindle assembly checkpoint. These data suggest that the APC/C is activated as cells enter mitosis and immediately targets cyclin A for degradation, whereas the spindle assembly checkpoint delays the degradation of cyclin B1 until the metaphase to anaphase transition. The “destruction box” (D-box) of cyclin A is 10–20 residues longer than that of cyclin B. Overexpression of wild-type cyclin A delayed the metaphase to anaphase transition, whereas expression of cyclin A mutants lacking a D-box arrested cells in anaphase.

1 May 2000 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
Edgar Richard KramerEdgar Richard Kramer
Edgar Richard Kramer
NSNadja Scheuringer
Nadja Scheuringer
APAlexandre V. Podtelejnikov
Alexandre V. Podtelejnikov
MMMatthias Mann
Matthias Mann
JPJan-Michael Peters
Jan-Michael Peters
The ordered activation of the ubiquitin protein ligase anaphase-promoting complex (APC) or cyclosome by CDC20 in metaphase and by CDH1 in telophase is essential for anaphase and for exit from mitosis, respectively. Here, we show that CDC20 can only bind to and activate the mitotically phosphorylated form of theXenopus and the human APC in vitro. In contrast, the analysis of phosphorylated and nonphosphorylated forms of CDC20 suggests that CDC20 phosphorylation is neither sufficient nor required for APC activation. On the basis of these results and the observation that APC phosphorylation correlates with APC activation in vivo, we propose that mitotic APC phosphorylation is an important mechanism that controls the proper timing of APCCDC20activation. We further show that CDH1 is phosphorylated in vivo during S, G2, and M phase and that CDH1 levels fluctuate during the cell cycle. In vitro, phosphorylated CDH1 neither binds to nor activates the APC as efficiently as does nonphosphorylated CDH1. Nonphosphorylatable CDH1 mutants constitutively activate APC in vitro and in vivo, whereas mutants mimicking the phosphorylated form of CDH1 are constitutively inactive. These results suggest that mitotic kinases have antagonistic roles in regulating APCCDC20and APCCDH1; the phosphorylation of APC subunits is required to allow APC activation by CDC20, whereas the phosphorylation of CDH1 prevents activation of the APC by CDH1. These mechanisms can explain the temporal order of APC activation by CDC20 and CDH1 and may help to ensure that exit from mitosis is not initiated before anaphase has occurred.

1 June 2001 in Cell
Verified
Journal Article
Closed access
JRJulie D.R. Reimann
Julie D.R. Reimann
EFEllen Freed
Ellen Freed
JHJerry Y. Hsu
Jerry Y. Hsu
Edgar Richard KramerEdgar Richard Kramer
Edgar Richard Kramer
JPJan-Michael Peters
Jan-Michael Peters
PJPeter K. Jackson
Peter K. Jackson

25 December 2011 in Nature Medicine
Verified
Journal Article
Closed access
AEAli Ertürk
Ali Ertürk
CMChristoph P Mauch
Christoph P Mauch
FHFarida Hellal
Farida Hellal
FFFriedrich Förstner
Friedrich Förstner
TKTara Keck
Tara Keck
FBFrank Bradke
Frank Bradke

15 September 2000 in Genes & Development
Verified
Journal Article
Open access
PDF file
BPBirgit Otzen Petersen
Birgit Otzen Petersen
CWChristian Wagener
Christian Wagener
FMFederica Marinoni
Federica Marinoni
Edgar Richard KramerEdgar Richard Kramer
Edgar Richard Kramer
MMMarina Melixetian
Marina Melixetian
KHKristian Helin
Kristian Helin
CDC6 is conserved during evolution and is essential and limiting for the initiation of eukaryotic DNA replication. Human CDC6 activity is regulated by periodic transcription and CDK-regulated subcellular localization. Here, we show that, in addition to being absent from nonproliferating cells, CDC6 is targeted for ubiquitin-mediated proteolysis by the anaphase promoting complex (APC)/cyclosome in G1. A combination of point mutations in the destruction box and KEN-box motifs in CDC6 stabilizes the protein in G1 and in quiescent cells. Furthermore, APC, in association with CDH1, ubiquitinates CDC6 in vitro, and both APC and CDH1 are required and limiting for CDC6 proteolysis in vivo. Although a stable mutant of CDC6 is biologically active, overexpression of this mutant or wild-type CDC6 is not sufficient to induce multiple rounds of DNA replication in the same cell cycle. The APC–CDH1-dependent proteolysis of CDC6 in early G1 and in quiescent cells suggests that this process is part of a mechanism that ensures the timely licensing of replication origins during G1.

1 October 1999 in Nature
Verified
Journal Article
Closed access
CLClaudia Lukas
Claudia Lukas
Claus SørensenClaus Sørensen
Claus Sørensen
Edgar Richard KramerEdgar Richard Kramer
Edgar Richard Kramer
ESEric Santoni-Rugiu
Eric Santoni-Rugiu
CLClaes Lindeneg
Claes Lindeneg
JLJiri Lukas
Jiri Lukas